Columbia Asia to invest Rs 400 crore on 2 new hospitals in India

download (2).pngSource: Financial Express, June 28, 2017

New Delhi: International healthcare firm Columbia Asia will invest over Rs 400 crore to set up two new hospitals in India by the end of 2019 as it looks to expand presence in the country. The chain currently has 11 multi-speciality hospitals in India with over 1,000 beds in cities such as Bengaluru, Kolkata, Ahmedabad, Mysuru, Gurugram, Ghaziabad, Patiala, and Pune. “We are planning to open two hospitals in the country by the end of 2019. The investment on this will be over Rs 400 crore”, Columbia Asia India Chairman, CEO and GMD Nandakumar Jairam told PTI. The new hospitals will be located in Bengaluru and Pune, he added. “With the opening of

Read the rest of this entry »

Norms eased for makers of biologic products

Source: The Economic Times, Dec 17, 2016

NEW DELHI: India’s drug regulator has eased licencing norms for vaccine and recombinant-DNA manufacturers in a move expected to promote research and development of new drugs in the country.

The Central Drugs Standard Control Organisation (CDSCO) has done away with the need for joint inspections to issue licences to allow such companies to make biologic products for testing and analysis purposes. The regulator has also clarified that these biologics can also be exported only for the purpose of examination, test or analysis and not for commercial purposes in a circular dated December 13.

According to CDSCO’s latest decision, State Licencing Authorities will issue ‘Form 29’ licences to vaccine and r-DNA makers within three working days of them submitting their application. The joint inspection of these applicants will now be carried out using a risk-based approach only after the licence is issued.

Form 29 licences are issued to allow companies to manufacture biological products for examination, testing or analytical purposes.

Medical tourism earnings to enter growth figures

index.jpgSource: The Economic Times, Dec 05, 2016

NEW DELHI: The government will estimate for the first the income it earns from medical tourism and include it to calculate India’s growth figure, a move aimed at making the country’s services data and growth numbers comprehensive.

The data will also be used for improving policy for the sector. The government is seeking details of the number of people who come from other countries for treatment, main countries from where they come and the kind of medical treatment they undergo. As part of the survey, data is being collected on services being provided to foreigners or non-resident Indians (exports), services being availed from overseas hospitals (imports), temporary overseas movement of personnel, clinical consultations, telemedicine and, services of doctors, nurses and midwives in foreign countries.

Read the rest of this entry »

Medical tourism earnings to enter growth figures

index.jpgSource: The Economic Times, Dec 05, 2016

NEW DELHI: The government will estimate for the first the income it earns from medical tourism and include it to calculate India’s growth figure, a move aimed at making the country’s services data and growth numbers comprehensive.

The data will also be used for improving policy for the sector. The government is seeking details of the number of people who come from other countries for treatment, main countries from where they come and the kind of medical treatment they undergo. As part of the survey, data is being collected on services being provided to foreigners or non-resident Indians (exports), services being availed from overseas hospitals (imports), temporary overseas movement of personnel, clinical consultations, telemedicine and, services of doctors, nurses and midwives in foreign countries.

Read the rest of this entry »

Corporate hospitals see big jump in patients from abroad

Source: The Hindu Business Line, Oct 16, 2016

Hyderabad: Corporate hospitals in India are increasingly attracting foreign patients for treatment which is boosting the country’s image as a hub of medical tourism.According to data available with industry experts, number of patients from abroad visiting India for treatment has been growing by 23 to 25 per cent per annum.

“Data from eight hospitals of Apollo Group which are entitled to treat foreign patients and informal data we collate from other players show this kind of surge in number of visits to India for treatment,’’ Radhe Mohan, Vice President – International Marketing Apollo Health City told Business Line.

Apollo group alone treated 1.50 lakh foreign patients in the last financial year ended March, 2016 and is expecting a 25 per cent growth in this number this year, Mohan said.

Read the rest of this entry »

Government looks to fast-track approvals for clinical trials

Source: The Economic Times, Oct 14, 2016

NEW DELHI: As the government reviews an overhaul of the drug regulatory process, rules related to clinical trials may be further eased and timelines for approvals shortened to four to six months from around six to eight months now.

The central drug regulator plans to fast track the approval process for clinical trials while ensuring that the contract research organisations (CROs) involved in the tests comply with stricter quality and compliance checks.

This comes two months after the drug regulatory agency eased rules related to clinical research — a move that was frowned upon by patient rights groups. These rules let investigators undertake as many trials as approved under the watch of the designated ethics committee and could risk patient lives, groups like Swasthya Adhikaar Manch earlier told ET. “(There will be) changes to the (regulations) to make it both easy and stringent,” a senior health ministry official told ET, speaking about the government’s upcoming move on the condition of anonymity.

Read the rest of this entry »